Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea-Reference-Cited by-同舟云学术

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea

Published:2008-12-01 Issue:1 Volume:25 Page:65-75
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Bergenstal Richard¹,Lewin Andrew²,Bailey Timothy³,Chang Denise⁴,Gylvin Titus⁴,Roberts Victor⁵,

Affiliation:

1. International Diabetes Center at Park Nicollet, Minneapolis, MN, USA

2. National Research Institute, Los Angeles, CA, USA

3. AMCR Institute Inc., Escondido, CA, USA

4. Novo Nordisk Inc., Princeton, NJ, USA

5. Endocrine Clinical Research, Winter Park, FL, USA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007990802597951

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review of type 2 diabetes mellitus and its management in children and adolescents;Pediatric Medicine;2024-02

2. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update;Endocrine Practice;2022-10

3. A Review on the Structure and Anti-Diabetic (Type 2) Functions of β-Glucans;Foods;2021-12-27

4. Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin;Metabolism;2019-09

5. Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine;Diabetes/Metabolism Research and Reviews;2019-01-07